Table 1 Summary and comparison of the clinical manifestations and treatment choices of small intestinal stromal tumors at different sites
From: Unraveling the site-specific features in small intestinal stromal tumors: a retrospective study
Variables | Duodenum# | Jejunum# | Ileum# | P value | P value Between groups |
|---|---|---|---|---|---|
Sex (male) | 61 (54.5%) | 66 (58.4%) | 40 (43.5%) | 0.093 | / |
Age of onset | 52.4 ± 11.5 | 53.2 ± 12.8 | 57.8 ± 13.4 | 0.006* | Duodenum vs. Jejunum 1.000 Jejunum vs. Ileum 0.031* Duodenum vs. Ileum 0.007* |
Age at surgery | 53.6 ± 11.4 | 54.16 ± 12.0 | 58.5 ± 13.3 | 0.009* | Duodenum vs. Jejunum 1.000 Jejunum vs. Ileum 0.034* Duodenum vs. Ileum 0.013* |
Duration of disease | 165.0 (60.0, 365.0) | 60.0 (20.5, 300.0) | 60.0 (30.0, 262.5) | 0.001* | Duodenum vs. Jejunum 0.002* Jejunum vs. Ileum 1.000 Duodenum vs. Ileum 0.014* |
Duration of GIB | 120.0 (37.5, 365.0) | 60.0 (13.75, 542.5) | 90.0 (30.0, 605.0) | 0.208 | / |
No symptom | 32 (28.6%) | 22 (19.5%) | 21 (22.8%) | 0.268 | / |
Abdominal pain | 18 (16.1%) | 21 (18.6%) | 28 (30.4%) | 0.031* | Duodenum vs. Jejunum 0.619 Jejunum vs. Ileum 0.048 Duodenum vs. Ileum 0.015* |
Abdominal bloating | 13 (11.6%) | 5 (4.4%) | 5 (5.4%) | 0.084 | / |
Abdominal mass | 1 (0.9%) | 13 (11.5%) | 7 (7.6%) | 0.005* | Duodenum vs. Jejunum < 0.001* Jejunum vs. Ileum 0.350 Duodenum vs. Ileum 0.024 |
Weight loss | 16 (14.3%) | 17 (15.0%) | 15 (16.3%) | 0.922 | / |
Intratumoral hemorrhage | 2 (1.8%) | 5 (4.4%) | 7 (7.6%) | 0.127 | / |
tumor rupture | 1 (1%) | 2 (2%) | 2 (2%) | 0.860 | / |
Bowel obstruction | 3 (2.7%) | 9 (8.0%) | 5 (5.4%) | 0.212 | / |
Intestinal perforation | 1 (0.9%) | 0 (0.0%) | 3 (3.3%) | 0.071 | / |
Gynecological surgery | 1 (0.9%) | 4 (3.5%) | 29 (31.5%) | <0.001* | Duodenum vs. Jejunum 0.369 Jejunum vs. Ileum <0.001* Duodenum vs. Ileum <0.001* |
Emergency surgery | 4 (3.6%) | 19 (16.8%) | 10 (10.9%) | 0.005* | Duodenum vs. Jejunum 0.001* Jejunum vs. Ileum 0.224 Duodenum vs. Ileum 0.040 |
Preoperative neoadjuvant therapy | 9 (8.0%) | 6 (5.3%) | 4 (4.3%) | 0.505 | / |
Postoperative targeted therapy | 33 (29.5%) | 53 (46.9%) | 59 (64.1%) | <0.001* | Duodenum vs. Jejunum 0.007* Jejunum vs. Ileum 0.014* Duodenum vs. Ileum <0.001* |